Short-term outcomes of enhanced recovery after surgery protocol in robotic-assisted McKeown esophagectomy for esophageal cancer: a single-center retrospective cohort study.

Background: This study aimed to evaluate the short-term outcomes of enhanced recovery after surgery (ERAS) protocol in perioperative robotic-assisted McKeown esophagectomy (RAME) among esophageal cancer patients.

Methods: For this retrospective study, all patients who had undergone RAME with esophageal cancer using ERAS protocol and conventional management strategy at the surgery center of our hospital from February 2019 to March 2022 were performed for analysis.

Results: A total of 211 patients were included.

Serum Hsa_circ_0005962 Is A Prognostic Biomarker of Paclitaxel Resistance in Nonsmall Cell Lung Cancer Treatment.

Background: Tumor progression and the therapeutic resistance associated with cancer agents are thought to be modulated by circular RNAs (circRNAs); however, its mechanism associated with nonsmall cell lung cancer (NSCLC) is still undetermined. The following investigation aimed to evaluate the involvement of circRNAs with NSCLC.

Methods: The serum specimens of 146 NSCLC individuals who received complete four cycles of PTX chemotherapy were collected.

Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2.

Background: Circular RNAs (circRNAs) demonstrated critical roles within developing tumors and treatment resistance in an increasing body of research. The aim was to look into the functions and processes of hsa_circ_0003489 in the non-small cell lung cancer (NSCLC) paclitaxel (PTX) resistance.

Methods: NSCLC cell-based cultures including A549 and H460 were employed for such an investigation.

Hsa_circ_0003220 Drives Chemoresistance of Human NSCLC Cells by Modulating miR-489-3p/IGF1.

Circular RNAs (circRNAs) have been shown to have critical roles in developing cancer and treatment resistance in an increasing body of research. The aim was to look into the functions and processes of hsa_circ_0003220 in the non-small cell lung cancer (NSCLC) chemoresistance. The NSCLC cell lines H460 and A549 were employed in present work.

A meta-analysis of survival of patients with second primary non-small cell lung cancer after pulmonary lobectomy and partial pulmonary lobectomy.

Objective: A meta-analysis of the screened data was performed to investigate the survival status of patients with second primary non-small cell lung cancer (SPNSCLC) after pulmonary lobectomy and partial pulmonary lobectomy, and assess the applicability of such option in the treatment of such disease.

Methods: Based on the databases of PubMed, Ovid, and CNKI, relevant reports on postoperative survival of patients with SPNSCLC were obtained, and the information, including authors, publication year, research type, tumor staging, tumor diameter, surgical options, reasons for resection, and overall survival (OS), was extracted. The data were analyzed using Review Manager 5.

Development of an algal treatment system for selenium removal: Effects of environmental factors and post-treatment processing of Se-laden algae.

In developing an algal treatment system, selenium (Se) removal efficiency by Chlorella vulgaris was evaluated under various conditions such as Se concentration, algal density, temperature and pH. A maximum removal efficiency plateau of ∼90% was observed between 1000-3000 μg Se/L while the tolerance of Se toxicity was found at 6000 μg Se/L. C.